Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Submit a comment

Negative regulation of human IL-33 in endothelium during allergic airway inflammation
Maile K. Hollinger, Chanie L. Howard, Donna C. Decker, Kelly M. Blaine, Ivy Aneas, Emily M. Grayson, Tania E. Velez, Fernando A. Oliveira, Riley T. Hannan, Daniel F. Camacho, Philip A. Verhoef, Cara L. Hrusch, Rebecca S. Griffes, Jeffrey M. Sturek, Marcelo A. Nobrega, Nathan Schoettler, Anne I. Sperling
Maile K. Hollinger, Chanie L. Howard, Donna C. Decker, Kelly M. Blaine, Ivy Aneas, Emily M. Grayson, Tania E. Velez, Fernando A. Oliveira, Riley T. Hannan, Daniel F. Camacho, Philip A. Verhoef, Cara L. Hrusch, Rebecca S. Griffes, Jeffrey M. Sturek, Marcelo A. Nobrega, Nathan Schoettler, Anne I. Sperling
View: Text | PDF
Research Article Immunology Vascular biology

Negative regulation of human IL-33 in endothelium during allergic airway inflammation

  • Text
  • PDF
Abstract

Lung IL-33 is involved in pathogen defense, barrier homeostasis, and development of allergic responses. We previously identified a 5 kb noncoding region within a GWAS-defined segment that regulates expression of human IL33 (hIL33) but is absent in the murine locus. To understand how this region affects IL-33 expression in vivo, we engineered 2 BAC-transgenic strains in which 166 kb of the human genome upstream of the hIL33 locus, along with a fluorescent reporter, was inserted into the murine genome, both with and without the 5 kb region. Comparison to a murine Il33 (mIl33) reporter strain revealed species-specific tropism; hIL33 reporter was mostly expressed in the endothelium, while mIl33 reporter was expressed in type 2 alveolar epithelium. hIL33 reporter expression in tracheal basal epithelium, submucosal glands, and lung microvasculature required the 5 kb region. Surprisingly, allergen and exogenous IL-33 downregulated hIL33 reporter in lung endothelium only when the 5 kb region was present. Similar IL-33–dependent downregulation of IL33 transcripts was observed in human endothelial cell lines, validating that our hIL33 reporter strain recapitulated human endothelial biology. Together, these data reveal the importance of the asthma-associated human 5 kb region in regulating human IL33 expression in a cell type– and context-dependent manner.

Authors

Maile K. Hollinger, Chanie L. Howard, Donna C. Decker, Kelly M. Blaine, Ivy Aneas, Emily M. Grayson, Tania E. Velez, Fernando A. Oliveira, Riley T. Hannan, Daniel F. Camacho, Philip A. Verhoef, Cara L. Hrusch, Rebecca S. Griffes, Jeffrey M. Sturek, Marcelo A. Nobrega, Nathan Schoettler, Anne I. Sperling

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts